Drugs Made In America Acquisition (DMAA) Notes Payables (2024 - 2025)
Drugs Made In America Acquisition (DMAA) reported Notes Payables of $60898.0 for Q1 2025, down 90.81% quarter-over-quarter from $662324.0 in Q4 2024.
Drugs Made In America Acquisition (DMAA) Notes Payables (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition has reported Notes Payables for 2 years, with the latest figure at $60898.0 in Q1 2025.
- For the quarter ending Q1 2025, Notes Payables changed N/A year-over-year to $60898.0; the trailing twelve-month figure through Mar 2025 stood at $60898.0 (changed N/A YoY), and the FY2024 full-year result was $662324.0, changed N/A from the prior year.
- Notes Payables for Q1 2025 stood at $60898.0, down from $662324.0 in the prior quarter.
- The five-year high for Notes Payables was $662324.0 in Q4 2024, with the low at $60898.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 312.46 Mn | 312.46 Mn | - |
| 3 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - |
| 5 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - |
| 7 | Bold Eagle Acquisition | 275.54 Mn | 275.54 Mn | - |
| 8 | Soulpower Acquisition | 264.91 Mn | 264.91 Mn | - |
| 9 | BTC Development | 262.16 Mn | 262.16 Mn | - |
| 10 | Drugs Made In America Acquisition | 223.11 Mn | 223.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 60,898.00 |
| Dec 31, 2024 | 662,324.00 |